Work

Mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed/refractory solid tumors: Dose expansion results.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.3027

Authors: Benedito A. Carneiro, Ruth Perets, Afshin Dowlati, Patricia LoRusso, Kan Yonemori, Lei He, Wijith Munasinghe, Behnam Noorani, Eric Feral Johnson, Jon Zugazagoitia

Institutions: Brown University, Rambam Health Care Campus, University Hospitals Seidman Cancer Center, Case Western Reserve University, National Cancer Center Hospital, AbbVie (United States), Hospital Universitario 12 De Octubre

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379283656

Cites:

Cited by: 20

Related to: 10